Month: May 2020

May 20 2020

Uncategorized

Study uncovers new applications for schizophrenia drug

by Clinical Editor

No Comments

A schizophrenia drug may be able to significantly reduce swelling from brain and spinal cord injuries, scientists have found. The discovery could lead to a safe treatment for millions of...

May 20 2020

Uncategorized

New drug target for schizophrenia

by Clinical Editor

No Comments

Scientists find that the brains of people with schizophrenia have lower levels of a key lipid. The findings could lead to new treatments for schizophrenia.

May 20 2020

Uncategorized

Anti-PDHA1 antibody is detected in a subset of patients with schizophrenia

by Clinical Editor

No Comments

Autoantibodies have been implicated in schizophrenia aetiology. Here, novel autoantibodies were isolated from Autoantibody candidates were searched us …

May 20 2020

Uncategorized

Study IDs Potential New Drug Target for Schizophrenia

by Clinical Editor

No Comments

Japanese researchers have discovered a deficiency in the brains of people with schizophrenia. The findings could lead to the development of new drug therapies. For the study, researchers at the...

May 19 2020

Uncategorized

Anti-PDHA1 antibody is detected in a subset of patients with schizophrenia

by Clinical Editor

No Comments

Autoantibodies have been implicated in schizophrenia aetiology. Here, novel autoantibodies were isolated from Autoantibody candidates were searched us …

May 19 2020

Uncategorized

Study uncovers new applications for schizophrenia drug

by Clinical Editor

No Comments

A schizophrenia drug may be able to significantly reduce swelling from brain and spinal cord injuries, scientists have found. The discovery could lead to a safe treatment for millions of...

May 19 2020

Uncategorized

Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies

by Clinical Editor

No Comments

Over the past 25 years, studies analyzing post-mortem brain samples have found evidence of aberrant glycosylation in individuals with schizophrenia. Proteins involved in both excitatory and inhibitory …

May 19 2020

Uncategorized

New drug target for schizophrenia

by Clinical Editor

No Comments

Scientists find that the brains of people with schizophrenia have lower levels of a key lipid. The findings could lead to new treatments for schizophrenia.

May 19 2020

Uncategorized

Study IDs Potential New Drug Target for Schizophrenia

by Clinical Editor

No Comments

Japanese researchers have discovered a deficiency in the brains of people with schizophrenia. The findings could lead to the development of new drug therapies. For the study, researchers at the...

May 18 2020

Uncategorized

Study uncovers new applications for schizophrenia drug

by Clinical Editor

No Comments

A schizophrenia drug may be able to significantly reduce swelling from brain and spinal cord injuries, scientists have found. The discovery could lead to a safe treatment for millions of...